Insider Trading (SEC Form 4)


Insiders are officers, directors, or significant investors. This page shows recent insider transactions for Pharmaceutical.

Transaction
Date
CompanyInsider Code
(see below)
Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
GALE WOOD BARBARA A (EVP, Gen. Counsel, Corp. Sec.) 0
KBIO Savage Robert G. (Director) 20,000
KBIO Savage Robert G. (Director) 20,000
OREX Moglia Stephen A. (VP & Chief Accounting Officer) 3,388
OREX Moglia Stephen A. (VP & Chief Accounting Officer) 3,388
EGLT TIMMINS MEGAN C. (General Counsel) 3,000
EGLT TIMMINS MEGAN C. (General Counsel) 3,000
BTHE Upham Loraine (Chief Operating Officer) 1,554,858
CCXI Kwan Pui San (Principal Acctg Officer) 37,498
BTHE Upham Loraine (Chief Operating Officer) 1,554,858
CCXI Kwan Pui San (Principal Acctg Officer) 37,498
ENDP Barry Patrick A (EVP & Chief Commercial Officer) 69,475
ENDP Barry Patrick A (EVP & Chief Commercial Officer) 82,308
ENDP Barry Patrick A (EVP & Chief Commercial Officer) 75,897
ENDP Barry Patrick A (EVP & Chief Commercial Officer) 103,795
TTPH Edwards Larry G. (Chief Operating Officer) 56,064
ENDP Barry Patrick A (EVP & Chief Commercial Officer) 69,475
ENDP Barry Patrick A (EVP & Chief Commercial Officer) 82,308
ENDP Barry Patrick A (EVP & Chief Commercial Officer) 75,897
ENDP Barry Patrick A (EVP & Chief Commercial Officer) 103,795
TTPH Edwards Larry G. (Chief Operating Officer) 56,064
MRK THULIN INGE G (Director) 200
MRK THULIN INGE G (Director) 200
PGNX Osorio Benedict (Senior Vice President, Quality) 42,404
PGNX Osorio Benedict (Senior Vice President, Quality) 42,404
MEIP DRISCOLL FREDERICK W (Director) 0
ABUS VandenEnden Koert (Interim CFO) 5,500
ABUS VandenEnden Koert (Interim CFO) 5,500
CTLT Crane Rosemary A (Director) 2,386
CTLT GREISCH JOHN J (Director) 2,386
CTLT Kreuzburg Christa (Director) 2,386
CTLT Kreuzburg Christa (Director) 2,386
BMY Santiago Karen Murphy (Controller) 806
BMY Santiago Karen Murphy (Controller) 806
CTLT Crane Rosemary A (Director) 2,386
CTLT GREISCH JOHN J (Director) 2,386
CYTK RODDY PETER S (SVP Finance & CAO) 3,040
CYTK RODDY PETER S (SVP Finance & CAO) 3,040
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 2,044,307
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 1,510,693
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 2,044,307
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 1,510,693
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 2,044,307
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 1,510,693
AXON Bickerstaff George (Director) 0
AXON Cheruvu Pavan (Chief Executive Officer) 0
AXON JEFFS ROGER (Director) 0
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 2,044,307
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 1,510,693
CBIO Flynn James E (10% Owner) Deerfield Mgmt L.P. (10% Owner) DEERFIELD MANAGEMENT CO (10% Owner) DEERFIELD PARTNERS, L.P. (10% Owner) Deerfield Special Situations Fund, L.P. (10% Owner) 2,044,307
A
Grant, award, or other acquisition of securities from the company (such as an option)
K
Equity swaps and similar hedging transactions
P
Purchase of securities on an exchange or from another person
S
Sale of securities on an exchange or to another person
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
M
Exercise or conversion of derivative security received from the company (such as an option)
G
Gift of securities by or to the insider
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)